Patrycja Grabowska

Patrycja Grabowska

Auto-generated profile, based on publicly available information

Patrycja Grabowska

Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
AMAleksandra Madej
Aleksandra Madej
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
PBPatrycja Bolla
Patrycja Bolla
ASAleksandra Senat
Aleksandra Senat
MDMateusz Dorochowicz
Mateusz Dorochowicz
INTRODUCTION: Diabetes mellitus type 2 (DM2) is a widespread and chronic disorder with high mortality and associated morbidity rates worldwide. DM2 individuals are more susceptible to developing heart disease, cardiovascular disease, diabetic neuropathy, and several other related complications, which are major causes of diabetes related death. New therapies and possibilities for the treatment of the diabetes are constantly being searched for, among which the ketogenic diet is increasingly becoming popular. There are studies being conducted all worldwide on the effects of this diet on the treatment of diabetes. PURPOSE: The aim of the study is to present the current state of knowledge about the influence of the ketogenic diet on the therapy of type 2 diabetes. MATERIALS AND METHOD: The available literature in PubMed was reviewed to write the article, using the keywords ,,ketogenic diet”, ,,diabetes mellitus”, ,,ketogenic diet diabetes”, ,,diabetes nutrition”. CONCLUSION: A ketogenic diet has notable advantages on body weight and glycemic control, as well as on the enhancement of lipid profiles in overweight DM2 patients. This diet can decrease body weight, waist circumference, HbA1c, and triglycerides, and increase HDL levels. In addition, the ketogenic diet may have further benefits in improving body composition to attenuate the onset and progress of DM2 bz reducing body weight, lowering glycemic levels, and enhancing lipid profiles. More studies are needed in the future to support and even confirm the links between the ketogenic diet and patienst suffering from DM2.

12 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Madej
Aleksandra Madej
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
PBPatrycja Bolla
Patrycja Bolla
ASAleksandra Senat
Aleksandra Senat
ZMZuzanna Marczyńska
Zuzanna Marczyńska
INTRODUCTION: The term inflammatory bowel disease (IBD) refers to a chronic inflammatory disease of the gastrointestinal tract of unclear pathogenesis. IBD consists of ulcerative colitis (UC) and Crohn's disease (CD). The two most common manifestations of the disorder, both have a chronic course with episodes of acute activity. Their underlying pathogenesis and symptoms, however, are quite distinct. IBD has a multiple factor etiology involving genetics, immunological dysregulation and dysbiosis of the intestinal microbiome. The resulting chronic inflammation of the entire body is the cause of the symptoms and signs of the condition. Extraintestinal manifestations (EIM) occur in 5% to 50% of IBD patients over the course of their lifetime. PURPOSE: The aim of the study is to present the current state of knowledge about the prevalence of extraintestinal manifestations in Inflammatory Bowel Disease. MATERIALS AND METHOD: The available literature in PubMed was reviewed to write the article, using the keywords ,,inflammatory bowel disease”, ,,Crohn’s disease”, ,, ulcerative colitis”, ,,extraintestinal manifestations IBD”. CONCLUSION: Extraintestinal manifestations are evidence that IBD is not only confined to the intestine, these may involve many different organs other than the gut and may be more devastating than the IBD. Screening for EIM in these patients and prompt adequate treatment are essential. To adequately manage EIM and improve the quality of life of our patients, appropriate treatment regimens and therapies are required in a multidisciplinary team approach. Due to the lack of available dedicated diagnostic biomarkers for EIM, consideration of concomitant extraintestinal conditions in patients with inflammatory bowel disease might help in the selection and management of them. Clinicians caring for patients with IBD must be aware of these various systemic manifestations, as failure to diagnose and treat them early can result in significant morbidity.

4 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Madej
Aleksandra Madej
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
PBPatrycja Bolla
Patrycja Bolla
ASAleksandra Senat
Aleksandra Senat
ZMZuzanna Marczyńska
Zuzanna Marczyńska
Introduction: Sarcoidosis is a progressive chronic multisystemic inflammatory disease of unclear pathogenesis, which presents with noncaseating granulomas and is complicated to diagnose due to the variable clinical presentation of patients. Sarcoidosis may attack any organ, but especially the pulmonary, cutaneous, lymphatic, ocular, hepatic and splenic systems. The most frequent presentations are prolonged cough, rash, visual problems, peripheral lymphadenopathy, tiredness, and occasional abnormality of the chest X-ray. The diagnostic evaluation of sarcoidosis is difficult and often involves a combined effort of clinical data and appropriate imaging modalities. Purpose: The purpose of this article is to review the available literature on the epidemiology, clinical manifestations and management of patients with sarcoidosis Materials and method: The available literature in PubMed was reviewed to write the article, using the keywords ,,sarcoidosis”, ,,cardiac sarcoidosis”, ,,pulmonary sarcoidosis” and ,,cutaneous sarcoidosis”. Conclusion: Sarcoidosis is associated with a significant increase in patient mortality, as well as decreased quality of life and physical disability. Efforts to accurately predict disease progression allow for more comprehensive and personalized patient care. As a life threatening disease, sarcoidosis needs to be diagnosed early and treated appropriately.

22 January 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Madej
Aleksandra Madej
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
PBPatrycja Bolla
Patrycja Bolla
ASAleksandra Senat
Aleksandra Senat
MDMateusz Dorochowicz
Mateusz Dorochowicz
INTRODUCTION: Diabetes mellitus type II (DM2) is one of the most frequently diagnosed diseases worldwide with a constantly increasing prevalence. It represents an important clinical challenge. The studies are concentrating on improving our knowledge of both pathogenesis and therapeutic opportunities. The influence of intestinal flora on many health conditions is being investigated. It was found that the gut microbiota of the healthy and diabetic individuals are different. This provides a highly important focus for the consideration of whether and how, based on the content of the intestinal flora, the development and treatment of this disease and its complications can be affected. PURPOSE: The aim of the study is to present the current state of knowledge about the The role of the gut microbiota in the pathogenesis and therapy of type 2 diabetes. MATERIALS AND METHOD: The available literature in PubMed was reviewed to write the article, using the keywords ,,gut microbiota diabetes”, ,,diabetes mellitus”, ,,intestinal microbiome diabetes”, ,,dysbiosis diabetes” and ,,gut microbiota diabetes”. CONCLUSION: The intestinal microbiome is a diverse community of microorganisms that inhabit the gut and has been shown to be essential for the health of the body. Modifications in the diversity and frequency of microorganisms residing in the gut, and the accumulation of metabolites they generate, have been correlated with DM2. The study of intestinal microflora could lead to the discovery of new methods of diagnosis and therapies of DM2 and its complications, such as diabetic kidney disease, neuropathy, retinopathy and cardiovascular disease. In conclusion, further studies are needed to understand the role of the gut microbiome in the pathogenesis and therapy of DM2.

13 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
ASAleksandra Senat
Aleksandra Senat
PBPatrycja Bolla
Patrycja Bolla
AMAleksandra Madej
Aleksandra Madej
KLKarolina Libracka
Karolina Libracka
Endometriosis is a common disease. It affects 5-10% of women of reproductive age worldwide. However, despite the prevalence, diagnosis is typically delayed by years, misdiagnosis is common, and effective treatment takes years to achieve. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Three main typed of endometriosis have been described in literature: peritoneal, ovarian and deep infiltrative. This is mainly due to the most common locations of ectopis endometrium. .Determining the precise pathogenesis of endometriosis has proved challenging and controversial for gynecologists, endocrinologists and researchers, but recent studies have focused on finding answers. This disease is often asymptomatic and diagnosed incidentally during various surgical interventions or follow-up gynecological examinations. Epidemiological research reports that women with this disease are more vulnerable to ovarian and breast cancer, asthma, skin cancer suhc as melanoma, cardiovascular disease and rheumatoid arthritis. The connection of the gut microbiota and endometriosis is nowadays higly suspected to exist. Scientists are focused on the influence of the microbiome on estrogens, estrogens-dependent disorders, immune system and inflammation. It is strongly velieved that correction of the gut microbiota with antibiotica, probiotics, or fecal bacterial transplantation sie a hopeful method for improving the clinical management of endometriosis.

1 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
HSHanna Senat
Hanna Senat
PGPatrycja Grabowska
Patrycja Grabowska
ASAleksandra Senat
Aleksandra Senat
PBPatrycja Bolla
Patrycja Bolla
AMAleksandra Madej
Aleksandra Madej
ZMZuzanna Marczynska
Zuzanna Marczynska
The presented case study focuses on the complexities and challenges in diagnosingone of the forms of amyloidosis, where abnormal protein (amyloid) deposits in variousorgans and tissues lead to affection of many organs, especially the heart, kidneys, liver,spleen, and occasionally the central nervous system. Its aetiology remains largely unknown,making diagnosis and treatment particularly challenging.This report details the case of an 88-year-old patient, disabled for months (with amodified Rankin Scale score of 4), who presented to the Neurology Department with suddenright limb paresis and speech disorders. Initial assessments indicated suggested ischemicstroke, and patients received thrombolysis. Further laboratory tests and imaging, includingserum protein electrophoresis and computer tomograph (CT) scans, suggested transthyretinamyloidosis (ATTR), which was later confirmed through genetic testing.This case underscores the rapid, multi-organ progression of amyloidosis and itsdevastating impact, highlighting the necessity for early diagnosis and a multidisciplinarytreatment approach.Despite ongoing research, the pathogenesis of amyloidosis remains elusive, andcurrent treatment options are primarily symptomatic. This study aims to shed light on thediagnostic difficulties and the urgent need for timely intervention in amyloidosis cases.